BioMarck Pharmaceuticals

BioMarck Pharmaceuticals, Ltd. is a privately owned biopharmaceutical company dedicated to the discovery and development of new drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of mucus and pulmonary inflammation in patients with chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis.  WEBSTER VENTURES is an investor in BioMarck Pharmaceuticals.